Ajanta Pharma Ltd.

NSE: AJANTPHARM | BSE: 532331 | ISIN: INE031B01049 | Industry: Pharmaceuticals
| Expensive Performer
3380.1000 96.20 (2.93%)
NSE Oct 26, 2026 13:53 PM
Volume: 48,918
 

3380.10
2.93%
ICICI Direct
Branded generics traction, US momentum key differentiators- Branded business growth in India was significantly above the trendline and without one-offs, driven by 16 new launches over the last 9-12 months and improved coverage. The US also maintained the growth tempo on account of 8 new launches over the last 9-12 months and market share gain in the existing products. US traction is contrary to the existing industry trend as the focus remains on specific launches. Africa branded continued to be driven by new launches. Asia branded on the other hand witnessed...
Promoters unpledged 1.88% of shares in last quarter. Total pledge stands at 20.65% of promoter holdings
More from Ajanta Pharma Ltd.
Recommended